Non-linear saturation threshold of gonadotropin dose on cumulative live birth rates in advanced-age women with polycystic ovary syndrome: a retrospective cohort study

• by Yusi Han, Chunxiao Wei, Xinhua Wang, Jianwei Zhang

• May 20, 2026

A metabolic marker–based diagnostic model for precancerous and malignant endometrial lesions in insulin-resistant PCOS women with sonographically suspected endometrial polyps

• by Ying Yang, Ningning Hu, Weimin Fan, Liwen Zhang, He Fei, Jun Ye, Yang Gao, Ju Yang, Jiangnan Pei, Rujun Chen

• July 13, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

PCOS Renamed PMOS After Global Consensus

International initiative reframes a common endocrine disorder around its metabolic and ovarian features rather than ovarian cysts

• by Kerri Miller

• May 13, 2026

• 4 min